AGBL4 and central nervous system cancer: As a member of cytosolic carboxypeptidase family, although the role of AGBL4 in various cellular and pathological processes such as antiviral activity, immunomodulatory activity, and renal adenocarcinamo is documented (14–16), its function in central nervous system tumors, particularly GBM, has been less explored.